Amgen Inc (NASDAQ:AMGN) announced topline results from its Phase 3 trial evaluating the efficacy and safety of Uplizna ...
Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
The CD19-targeted rare disease medicine Uplizna was one of the crown jewels in Amgen’s $27.8 billion buyout of Horizon ...
The FDA's vaccine advisory panel voted to recommend that this fall’s Covid-19 shots should be updated to target Omicron’s ...
The lucrative obesity market is projected to hit $130B by 2030, with Eli Lilly and Novo Nordisk leading the charge. Amgen is ...
GSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care ...
A team at King’s College London has developed a “drug delivery cage” that can be filled with chemotherapy drugs.
Due to the risk of CRS and neurologic toxicity, including ICANS, monitor patients from the start of the IMDELLTRA TM infusion for 22 to 24 hours on Cycle 1 Day 1 and Cycle 1 Day 8 in an appropriate ...